HIF-1α deficiency perturbs T and B cell functions

被引:26
作者
Kojima, H
Sitkovsky, MV
Cascalho, M
机构
[1] Mayo Clin, Dept Surg, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA
[3] Dokkyo Univ, Sch Med, Inst Med Sci, Div Immunol, Mibu, Tochigi 321093, Japan
[4] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
HIF-1; alpha; T-lymphocyte; B-lymphocyte; lymphocyte development;
D O I
10.2174/1381612033454388
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The immune system protects organisms from pathogens. The immune cells, in particular T- and B-lymphocytes, develop and acquire effector functions in specialized tissues called the lymphoid organs. The lymphoid organs exhibit lower oxygen tensions than the blood or the atmosphere. Furthermore, inflammatory and tumor environments where lymphocytes execute effector functions also have very low,oxygen tensions. These findings led to the hypothesis that lymphocytes may have evolved adaptive mechanisms to function under hypoxic conditions. Cellular responses to hypoxia are triggered by the hypoxia inducible factor-1alpha (HIF-1alpha). In this paper we review the development and function of T- and B-lymphocytes in the absence HIF-1alpha. Our studies suggest that HIF-1alpha deficiency depresses the function of cytotoxic T-lymphocytes and blocks B-cell development in the bone marrow. B1 lymphocytes of fetal origin, on the other hand, accumulate and may produce auto-antibodies and autoimmunity.
引用
收藏
页码:1827 / 1832
页数:6
相关论文
共 50 条
[1]   Cytokine therapeutics for asthma: An appraisal of current evidence and future prospects [J].
Alvarez, D ;
Wiley, RE ;
Jordana, M .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (11) :1059-1081
[2]   Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions [J].
Caldwell, CC ;
Kojima, H ;
Lukashev, D ;
Armstrong, J ;
Farber, M ;
Apasov, SG ;
Sitkovsky, MV .
JOURNAL OF IMMUNOLOGY, 2001, 167 (11) :6140-6149
[3]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[4]   Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7-/- mice [J].
Carvalho, TL ;
Mota-Santos, T ;
Cumano, A ;
Demengeot, J ;
Vieira, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (08) :1141-1150
[5]   RAG-2-DEFICIENT BLASTOCYST COMPLEMENTATION - AN ASSAY OF GENE-FUNCTION IN LYMPHOCYTE DEVELOPMENT [J].
CHEN, JZ ;
LANSFORD, R ;
STEWART, V ;
YOUNG, F ;
ALT, FW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4528-4532
[6]  
CHUKWUOCHA RU, 1995, J IMMUNOL, V154, P1246
[7]   LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE [J].
COHEN, PL ;
EISENBERG, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :243-269
[8]   Concepts of oxygen transport at the microcirculatory level [J].
Dewhirst, MW .
SEMINARS IN RADIATION ONCOLOGY, 1998, 8 (03) :143-150
[9]   GENETIC CONTRIBUTIONS TO LUPUS-LIKE DISEASE IN (NZBXNZW)F-1 MICE [J].
DRAKE, CG ;
ROZZO, SJ ;
VYSE, TJ ;
PALMER, E ;
KOTZIN, BL .
IMMUNOLOGICAL REVIEWS, 1995, 144 :51-74